| Financial Year |
March 31 2023 |
| Monetary Funds |
748,465,626.20 |
| Held-for-trading Financial Assets |
247,198,401.99 |
| Notes Receivable |
113,551,703.50 |
| Accounts Receivable |
1,781,054,060.15 |
| Advances to Suppliers |
67,276,252.05 |
| Other Receivables |
25,372,169.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
758,946.28 |
| Dividend Receivable |
-- |
| Inventories |
2,230,782,055.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,753,080.77 |
| Total Current Assets |
5,441,048,939.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,373,165.52 |
| Investment Properties |
5,153,194.99 |
| Fixed Assetes |
1,280,496,946.63 |
| Under-construction Projects |
119,210,028.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,111,373.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
129,464,610.38 |
| Other Non-Current Assets |
35,047,686.70 |
| Sub-Total of Non-Current Assets |
1,738,768,498.65 |
| Total Assets |
7,179,817,438.10 |
| Short-Term Loans |
779,131,587.91 |
| Trading Financial liabilities |
9,845,500.00 |
| Notes Payable |
627,072,867.57 |
| Accounts Payable |
1,115,632,062.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
74,812,327.93 |
| Taxes Payable |
17,548,919.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
352,235,902.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
301,919,684.77 |
| Other Current Liabilities |
144,857,167.79 |
| Sub-Total of Current Liabilities |
3,680,395,620.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,181,636.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,281,389.49 |
| Total Liabilities |
3,754,677,010.43 |
| Paid-In Capital(Or Share Stock) |
749,062,000.00 |
| Capital Surplus |
820,700,710.88 |
| Surplus Reserve |
374,531,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,377,460,666.10 |
| Minority Stockholder's Interest |
74,850,703.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,350,289,723.76 |
| Owner's Equity（Stockholder's Equity） |
3,425,140,427.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,179,817,438.10 |
